You just read:

inVentiv Health Consulting Survey of Biopharmaceutical Dealmakers Suggests Life Sciences Dealmaking to Return to Historic Norms in Year Ahead

News provided by

inVentiv Health

09 Jun, 2016, 14:04 ET